The Psychedelic Podcast cover image

Sam Mandel - 30,000 Infusions Later: Clinical Insights from a Ketamine Pioneer

The Psychedelic Podcast

00:00

Navigating the Future of Psychedelic Therapy Post-FDA Rejection

This chapter discusses the FDA's recent rejection of MDMA-assisted therapy and its impact on the landscape of psychedelic treatments, particularly ketamine therapy. The conversation highlights the necessity of a multidisciplinary approach in mental health care while advocating for patient safety and the incorporation of new therapies as they emerge.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app